DOV
50
-5
PPG
48
-2
UNH
32
10
SWKS
45
2
NWSA
80
-4
MHK
53
-2
SYF
74
-2
DD
60
3
JBHT
45
-4
APH
65
-6
CHRW
48
-2
KR
65
-3
DNB
52
-2
ISRG
52
2
AMGN
41
-3
ROP
48
12
ICE
49
-4
NWS
74
-4
ILMN
42
-3
KHC
36
-2
DOV
50
-5
PPG
48
-2
UNH
32
10
SWKS
45
2
NWSA
80
-4
MHK
53
-2
SYF
74
-2
DD
60
3
JBHT
45
-4
APH
65
-6
CHRW
48
-2
KR
65
-3
DNB
52
-2
ISRG
52
2
AMGN
41
-3
ROP
48
12
ICE
49
-4
NWS
74
-4
ILMN
42
-3
KHC
36
-2
Financhill
Back

BridgeBio Pharma Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
44

BBIO
BridgeBio Pharma

Last Price:
$46.54
Seasonality Move:
10.52%

7 Day Trial

ALL ACCESS PASS

$ 7

BridgeBio Pharma Stock Forecast

  • Over the next 52 weeks, BridgeBio Pharma has on average historically risen by 46.7% based on the past 6 years of stock performance.
  • BridgeBio Pharma has risen higher in 4 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
  • Is BridgeBio Pharma Stock Undervalued?
    The current BridgeBio Pharma [BBIO] share price is $46.51. The Score for BBIO is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • BBIO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will BridgeBio Pharma Stock Go Up Next Year?

  • Over the next 52 weeks, BridgeBio Pharma has on average historically risen by 46.7% based on the past 6 years of stock performance.

BridgeBio Pharma Stock Rating

Sell
44
BridgeBio Pharma (BBIO) is a Sell

Is BridgeBio Pharma overpriced?

  • BridgeBio Pharma has risen higher in 4 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

BridgeBio Pharma Stock Price History

Is BBIO stock going to rise?

  • The current trend is moderately bullish and BBIO is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
bridgebio.com

52-Week Data

52-Week High:
48.68
52-Week Low:
21.72

Prediction Charts

Market Cap:
8.8B
Price in USD:
46.51
Volume:
2.1M
Beta:
1.06

Technical Analysis

SMA50:
39.54
SMA100:
36.98
SMA200:
32.64
52-Wk Change:
79.37%

Stock Predictions

  • Is BridgeBio Pharma stock public?
    Yes, BridgeBio Pharma is a publicly traded company.
  • What is the BridgeBio Pharma stock quote today?
    The BridgeBio Pharma stock price is 46.51 USD today.
  • How to buy BridgeBio Pharma stock online?
    You can buy BridgeBio Pharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-30 45.13 43.18 45.23 42.94
Jul-1 43.00 42.78 43.04 41.80
Jul-2 42.42 42.83 43.16 42.12
Jul-3 42.63 43.99 44.07 42.29
Jul-7 43.77 43.50 43.77 42.95
Jul-8 43.68 43.19 44.03 43.15
Jul-9 44.26 45.98 46.43 43.91
Jul-10 46.09 46.27 46.80 45.93
Jul-11 45.98 46.47 46.76 45.73
Jul-14 47.34 47.69 48.68 46.80
Jul-15 48.19 46.97 48.42 46.63
Jul-16 47.29 47.10 47.66 46.70
Jul-17 47.02 46.74 47.48 46.59
Jul-18 47.05 46.51 47.36 46.14

BridgeBio Pharma Earnings

BridgeBio Pharma Earnings Report: Per Share BridgeBio Pharma Earnings Q1 Q2 Q3 and Q4 last year and next year.

BridgeBio Pharma Forecast Revenue Growth

BridgeBio Pharma Stock Analysis: Historical quarterly revenues per share for BridgeBio Pharma and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.28 per share, an increase next quarter of $0.19 per share, an increase this year of $0.17 per share, and an increase next year of $0.55 per share.

* BridgeBio Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.